Heart failure & cardiomyopathies

Impact of Improving Severity of Secondary Mitral Regurgitation on Survival

ESC Heart FailPublished Retrospective cohort study

Main finding · Long-term survivalResult — go to the resultHazard ratio 0.55 95% CI 0.32–0.96

Authors' conclusion

MT reduces SMR severity in 57% of the patients with severe SMR. A final SMR grade of ≤2+ is linked to improved survival, independently of the type of treatment they receive.

Study context

Population
Patients with severe secondary mitral regurgitation (SMR) and heart failure with reduced ejection fraction (HFrEF)435 evaluated
Participants
158 patients
Exposure
Responders vs non-responders; Medical therapy (MT) alone vs mitral valve (MV) intervention plus MT
  • Respondersn = 131
  • Non-respondersn = 27reference
Outcome
Long-term survival

Main finding

As reported in the abstract

Hazard ratio

0.55

95% CI 0.32–0.96

P = 0.032

Respondersvs Non-responders
HR 0.55 (95% CI 0.32–0.96); P = 0.032

Observational data: associations, not effects.

Further findings

MR severity improvement, by intervention type · 30 days

OutcomeHR (95% CI)P value
Survival by intervention type, overall populationMT alone n = 63; MV intervention plus MT n = 950.77 (0.48–1.26)P = 0.3
Survival by intervention type, within respondersMT alone n = 36; MV intervention plus MT n = 951.03 (0.56–1.89)P = 0.94

Original publication

Impact of Improving Severity of Secondary Mitral Regurgitation on Survival. ESC Heart Fail. Published 25 October 2022. doi:10.1002/ehf2.14196

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.